We found that there was inconsistency in the frequency distribution of CNAs in both of the data sets for those actionable genes from our list which are considered promising druggable targets for NSCLC, and colorectal cancer, such as KRAS, BRAF, EGFR, ATM, and PIK3CA. This evidence concerns the gene EGFR and colorectal cancer.